Clinical Trial Update: Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease [Phase 4]

View source ↗

Summary

This Phase 4 trial investigates the clinical and biomarker effects of Depot Medroxyprogesterone Acetate in females with sickle cell disease and is currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sickle Cell Disease

Drugs mentioned

• Depot Medroxyprogesterone Acetate (medroxyprogesterone acetate)

Snippet

Sponsor: University of Pennsylvania | Conditions: Sickle Cell Disease (SCD), Vaso-Occlusive Pain Episode in Sickle Cell Disease | Phase 4 | Status: RECRUITING